Source: Clinica Chimica Acta. Unidades: FCF, HU
Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA
ABNT
ARAZI, Simone Sorkin et al. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. Clinica Chimica Acta, v. 393, n. 2, p. 119-124, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2008.03.031. Acesso em: 18 nov. 2024.APA
Arazi, S. S., Genvigir, F. D. V., Willrich, M. A. V., Hirata, M. H., Dorea, E. L., Bernik, M. M. S., & Hirata, R. D. C. (2008). Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. Clinica Chimica Acta, 393( 2), 119-124. doi:10.1016/j.cca.2008.03.031NLM
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response [Internet]. Clinica Chimica Acta. 2008 ; 393( 2): 119-124.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.cca.2008.03.031Vancouver
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response [Internet]. Clinica Chimica Acta. 2008 ; 393( 2): 119-124.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.cca.2008.03.031